Yabao Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Yabao Pharmaceutical Group has a total shareholder equity of CN¥3.0B and total debt of CN¥93.9M, which brings its debt-to-equity ratio to 3.1%. Its total assets and total liabilities are CN¥3.7B and CN¥708.4M respectively. Yabao Pharmaceutical Group's EBIT is CN¥334.6M making its interest coverage ratio -247.5. It has cash and short-term investments of CN¥561.8M.
Key information
3.1%
Debt to equity ratio
CN¥93.87m
Debt
| Interest coverage ratio | -247.5x |
| Cash | CN¥561.80m |
| Equity | CN¥2.98b |
| Total liabilities | CN¥708.41m |
| Total assets | CN¥3.69b |
Financial Position Analysis
Short Term Liabilities: 600351's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥637.4M).
Long Term Liabilities: 600351's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥71.1M).
Debt to Equity History and Analysis
Debt Level: 600351 has more cash than its total debt.
Reducing Debt: 600351's debt to equity ratio has reduced from 40.9% to 3.1% over the past 5 years.
Debt Coverage: 600351's debt is well covered by operating cash flow (581.1%).
Interest Coverage: 600351 earns more interest than it pays, so coverage of interest payments is not a concern.